Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 13, 2025

Primary Completion Date

October 31, 2029

Study Completion Date

October 31, 2029

Conditions

Geographic AtrophyAge-Related Macular Degeneration

Interventions

DRUG

ABBV-6628

Intravitreal injection

DRUG

SYFOVRE

Intravitreal injection

Trial Locations (2)

RECRUITING

Retina Partners Midwest, P.C. /ID# 262172, Carmel

RECRUITING

Retina Foundation of the Southwest /ID# 262479, Dallas